Riboxx develops RNA molecules with unique properties. These molecules are dedicated to the following applications: - Vaccines: Development of dsRNA molecules that activate innate immunity. These are used as adjuvants for therapeutic vaccines (e.g. against cancer and infections) and prophylactic vaccines (e.g. against infections). - Oncology & Infections: Development of Toll-like receptor 3 (TLR3) agonists. TLR3 agonists are used in immunotherapy against cancer and/or infectious diseases. - Gene silencing: Development of customized and tailor-made molecular tools for gene silencing in vitro and in vivo.